CYTK Cytokinetics Inc

Cytokinetics Inc is a biopharmaceutical company. It is engaged in the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions.

$21.78  +0.47 (2.21%)
As of 06/21/2021 15:59:55 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  04/29/2004
Outstanding shares:  71,738,143
Average volume:  646,907
Market cap:   $1,573,934,857
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    23282W605
ISIN:        US23282W6057
Sedol:      BBBSBJ5
Valuation   (See tab for details)
PE ratio:   -11.32
PB ratio:   22.48
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy